SILO PHARMA, INC. Ttl Fee Amt
SILO PHARMA, INC. (SILO) had Ttl Fee Amt of $83.11 as of 2026-07-24, per its S-8 filed 2026-07-31.
Financial Statements › Notes
ffd:TtlFeeAmt · last filed 2026-07-31
- 2026-07-24: Ttl Fee Amt $83.11.
- 2026-07-21: Ttl Fee Amt $1.26K.
| Period end | Ttl Fee Amt |
|---|---|
| 2026-07-24 | $83.11 S-8 · filed 2026-07-31 |
| 2026-07-21 | $1.26K S-3 · filed 2026-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |